Logo image of A7A.DE

HELIAD AG (A7A.DE) Stock Fundamental Analysis

Europe - FRA:A7A - DE0001218063 - Common Stock

16.3 EUR
-0.1 (-0.61%)
Last: 10/24/2025, 7:00:00 PM
Fundamental Rating

3

Overall A7A gets a fundamental rating of 3 out of 10. We evaluated A7A against 114 industry peers in the Capital Markets industry. A7A has a medium profitability rating, but doesn't score so well on its financial health evaluation. A7A has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

A7A had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: A7A reported negative net income in multiple years.
A7A had negative operating cash flow in 4 of the past 5 years.
A7A.DE Yearly Net Income VS EBIT VS OCF VS FCFA7A.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.82%, A7A is in the better half of the industry, outperforming 62.83% of the companies in the same industry.
A7A has a Return On Equity of 3.59%. This is comparable to the rest of the industry: A7A outperforms 41.59% of its industry peers.
With a Return On Invested Capital value of 1.67%, A7A perfoms like the industry average, outperforming 54.87% of the companies in the same industry.
Industry RankSector Rank
ROA 2.82%
ROE 3.59%
ROIC 1.67%
ROA(3y)-3.65%
ROA(5y)-2.19%
ROE(3y)-4.7%
ROE(5y)-2.82%
ROIC(3y)N/A
ROIC(5y)N/A
A7A.DE Yearly ROA, ROE, ROICA7A.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

The Profit Margin of A7A (519.85%) is better than 98.23% of its industry peers.
A7A's Profit Margin has declined in the last couple of years.
The Operating Margin of A7A (431.95%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of A7A has grown nicely.
With an excellent Gross Margin value of 93.38%, A7A belongs to the best of the industry, outperforming 93.81% of the companies in the same industry.
A7A's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 431.95%
PM (TTM) 519.85%
GM 93.38%
OM growth 3Y132.69%
OM growth 5Y55.14%
PM growth 3YN/A
PM growth 5Y-11.53%
GM growth 3Y-0.25%
GM growth 5YN/A
A7A.DE Yearly Profit, Operating, Gross MarginsA7A.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

3

2. Health

2.1 Basic Checks

The number of shares outstanding for A7A remains at a similar level compared to 1 year ago.
Compared to 5 years ago, A7A has more shares outstanding
A7A has a worse debt/assets ratio than last year.
A7A.DE Yearly Shares OutstandingA7A.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
A7A.DE Yearly Total Debt VS Total AssetsA7A.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

A7A has an Altman-Z score of 4.89. This indicates that A7A is financially healthy and has little risk of bankruptcy at the moment.
A7A has a Altman-Z score of 4.89. This is amongst the best in the industry. A7A outperforms 84.07% of its industry peers.
A7A has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
A7A has a better Debt to Equity ratio (0.24) than 68.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 4.89
ROIC/WACCN/A
WACCN/A
A7A.DE Yearly LT Debt VS Equity VS FCFA7A.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

A7A has a Current Ratio of 0.57. This is a bad value and indicates that A7A is not financially healthy enough and could expect problems in meeting its short term obligations.
A7A has a Current ratio (0.57) which is in line with its industry peers.
A7A has a Quick Ratio of 0.57. This is a bad value and indicates that A7A is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.57, A7A perfoms like the industry average, outperforming 46.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
A7A.DE Yearly Current Assets VS Current LiabilitesA7A.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.16% over the past year.
A7A shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -46.21% yearly.
A7A shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.16%.
The Revenue for A7A have been decreasing by -33.67% on average. This is quite bad
EPS 1Y (TTM)114.16%
EPS 3YN/A
EPS 5Y-46.21%
EPS Q2Q%144.44%
Revenue 1Y (TTM)-40.16%
Revenue growth 3Y-52.27%
Revenue growth 5Y-33.67%
Sales Q2Q%611.32%

3.2 Future

The Earnings Per Share is expected to grow by 30.57% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y200%
EPS Next 2Y73.21%
EPS Next 3Y44.23%
EPS Next 5Y30.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
A7A.DE Yearly Revenue VS EstimatesA7A.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1M 2M 3M 4M 5M
A7A.DE Yearly EPS VS EstimatesA7A.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2023 2024 2025 2026 2027 2028 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 49.39 indicates a quite expensive valuation of A7A.
Compared to the rest of the industry, the Price/Earnings ratio of A7A is on the same level as its industry peers.
A7A is valuated expensively when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
A7A is valuated quite expensively with a Price/Forward Earnings ratio of 26.90.
The rest of the industry has a similar Price/Forward Earnings ratio as A7A.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.92, A7A is valued at the same level.
Industry RankSector Rank
PE 49.39
Fwd PE 26.9
A7A.DE Price Earnings VS Forward Price EarningsA7A.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
A7A.DE Per share dataA7A.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A7A's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A7A's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3Y44.23%

0

5. Dividend

5.1 Amount

No dividends for A7A!.
Industry RankSector Rank
Dividend Yield N/A

HELIAD AG

FRA:A7A (10/24/2025, 7:00:00 PM)

16.3

-0.1 (-0.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)09-30 2025-09-30
Earnings (Next)N/A N/A
Inst Owners0.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap137.08M
Revenue(TTM)529.00K
Net Income(TTM)2.75M
Analysts80
Price Target24.68 (51.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)200%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 49.39
Fwd PE 26.9
P/S 259.14
P/FCF N/A
P/OCF N/A
P/B 1.79
P/tB 1.79
EV/EBITDA N/A
EPS(TTM)0.33
EY2.02%
EPS(NY)0.61
Fwd EY3.72%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.06
BVpS9.11
TBVpS9.1
PEG (NY)0.25
PEG (5Y)N/A
Graham Number8.22
Profitability
Industry RankSector Rank
ROA 2.82%
ROE 3.59%
ROCE 2.93%
ROIC 1.67%
ROICexc 1.79%
ROICexgc 1.79%
OM 431.95%
PM (TTM) 519.85%
GM 93.38%
FCFM N/A
ROA(3y)-3.65%
ROA(5y)-2.19%
ROE(3y)-4.7%
ROE(5y)-2.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-8.62%
ROICexgc growth 5Y12.14%
ROICexc growth 3Y-8.62%
ROICexc growth 5Y12.14%
OM growth 3Y132.69%
OM growth 5Y55.14%
PM growth 3YN/A
PM growth 5Y-11.53%
GM growth 3Y-0.25%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z 4.89
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.16%
EPS 3YN/A
EPS 5Y-46.21%
EPS Q2Q%144.44%
EPS Next Y200%
EPS Next 2Y73.21%
EPS Next 3Y44.23%
EPS Next 5Y30.57%
Revenue 1Y (TTM)-40.16%
Revenue growth 3Y-52.27%
Revenue growth 5Y-33.67%
Sales Q2Q%611.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y454.81%
EBIT growth 3Y11.06%
EBIT growth 5Y2.9%
EBIT Next Year-100%
EBIT Next 3Y22.99%
EBIT Next 5Y16.49%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

HELIAD AG / A7A.DE FAQ

What is the ChartMill fundamental rating of HELIAD AG (A7A.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to A7A.DE.


Can you provide the valuation status for HELIAD AG?

ChartMill assigns a valuation rating of 3 / 10 to HELIAD AG (A7A.DE). This can be considered as Overvalued.


What is the profitability of A7A stock?

HELIAD AG (A7A.DE) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for A7A stock?

The Earnings per Share (EPS) of HELIAD AG (A7A.DE) is expected to grow by 200% in the next year.